Metabolic syndrome in HIV-positive patients

被引:8
|
作者
Drelichowska, Justyna [1 ,2 ]
Kwiatkowska, Wieslawa [1 ,2 ]
Knysz, Brygida [3 ]
Witkiewicz, Wojciech [1 ]
机构
[1] Reg Specialist Hosp Wroclaw, Wrovasc Integrated Cardiovas Ctr, Res Dev Ctr, Wroclaw, Poland
[2] Reg Specialist Hosp Wroclaw, Res Dev Ctr, Dept Angiol, Wroclaw, Poland
[3] Wroclaw Med Univ, Liver Diseasesand Acquired Immune Deficiencies, Dept Infect Dis, Wroclaw, Poland
来源
HIV & AIDS REVIEW | 2015年 / 14卷 / 02期
关键词
HIV; Antiretroviral therapy; Metabolic syndrome; Lipodystrophy; Hypertriglyceridemia; Cholesterol;
D O I
10.1016/j.hivar.2014.09.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A number of abnormalities related to chronic infection and antiretroviral treatment may be observed in a population of HIV-positive patients. A particular state of coexisting, interacting and interrelated disorders referred to as metabolic syndrome is observed in 7-45% of patients infected with HIV. Its presence is related to the abnormalities of adipose tissue distribution known under a common name of ART-related lipodystrophy syndrome. The most common features of metabolic syndrome observed in a course of HIV infection include hypertriglyceridemia and low HDL cholesterol concentration, while increased waist circumference is the least frequently observed. Treatment of metabolic syndrome encompasses revision and possible changes in antiretroviral therapy, diet, changes in physical activity, pharmacological management of individual components of the syndrome. In this publication we present a review of problems concerning epidemiology, pathophysiology, symptoms and treatment of metabolic syndrome in HIV-positive patients. (C) 2014 Polish AIDS Research Society. Published by Elsevier Sp.zo.o.All rights reserved.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 50 条
  • [41] Pancreatic exocrine insufficiency in HIV-positive patients
    Price, DA
    Schmid, ML
    Ong, ELC
    Adjukeiwicz, KMB
    Peatson, B
    Snow, MH
    HIV MEDICINE, 2005, 6 (01) : 33 - 36
  • [42] Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets
    Normen, L.
    Yip, B.
    Montaner, J.
    Harris, M.
    Frohlich, J.
    Bondy, G.
    Hogg, R. S.
    HIV MEDICINE, 2007, 8 (06) : 346 - 356
  • [43] ` Adequacy of pain management in HIV-positive patients
    Narasimooloo, C.
    Naidoo, S. S.
    Gaede, B. M.
    SOUTH AFRICAN FAMILY PRACTICE, 2011, 53 (01) : 71 - 76
  • [44] Nosocomial pulmonary infections in HIV-positive patients
    Petrosillo, N
    Nicastri, E
    Viale, P
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (03) : 231 - 235
  • [45] Diagnosis and treatment of spondylodiscitis in HIV-positive patients
    Siewe, Jan
    Oppermann, Johannes
    Eysel, Peer
    Zarghooni, Kourosh
    Sobottke, Rolf
    ACTA ORTHOPAEDICA BELGICA, 2013, 79 (05): : 475 - 482
  • [46] HIV-positive patients: ending discrimination and stigmatization
    Klumb S.
    Mörsch K.
    MMW - Fortschritte der Medizin, 2021, 163 (Suppl 2) : 48 - 56
  • [47] Hodgkin's disease in HIV-positive patients
    Costello, R
    Heuberger, L
    Petit, N
    Olive, D
    Gastaut, JA
    REVUE DE MEDECINE INTERNE, 1998, 19 (08): : 558 - 564
  • [48] REABSORPTION IN BONE METABOLISM OF HIV-POSITIVE PATIENTS
    Silva-Santos, Antonio Carlos
    Matos, Marcos Almeida
    Galvao-Castro, Bernardo
    ACTA ORTOPEDICA BRASILEIRA, 2009, 17 (02): : 50 - 52
  • [49] Potential benefits of carnitine in HIV-positive patients
    Rezaee, Haleh
    Khalili, Hossein
    Salamzadeh, Jamshid
    Jafari, Sirus
    Abdollahi, Alireza
    FUTURE VIROLOGY, 2012, 7 (01) : 73 - 83
  • [50] Paronychia in HIV-positive patients treated with indinavir
    García, MJG
    Amado, LEM
    Rodríguez, FA
    Alvarez, CM
    Hermida, AO
    REVISTA CLINICA ESPANOLA, 2001, 201 (08): : 455 - 458